BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15807879)

  • 1. Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency.
    McCallum RW; Sainsbury CA; Spiers A; Dominiczak AF; Petrie JR; Sattar N; Connell JM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):473-9. PubMed ID: 15807879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.
    Evans LM; Davies JS; Anderson RA; Ellis GR; Jackson SK; Lewis MJ; Frenneaux MP; Rees A; Scanlon MF
    Eur J Endocrinol; 2000 Mar; 142(3):254-62. PubMed ID: 10700719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
    Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.
    Smith JC; Evans LM; Wilkinson I; Goodfellow J; Cockcroft JR; Scanlon MF; Davies JS
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):493-501. PubMed ID: 11966742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity.
    Christ ER; Chowienczyk PJ; Sönksen PH; Russel-Jones DL
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):21-5. PubMed ID: 10468961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth hormone replacement therapy on plasma diacron-reactive oxygen metabolites and endothelial function in Japanese patients: The GREAT clinical study.
    Suzuki K; Yanagi K; Shimizu M; Wakamatsu S; Niitani T; Hosonuma S; Sagara M; Aso Y
    Endocr J; 2018 Jan; 65(1):101-111. PubMed ID: 29070768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk.
    Abdu TA; Elhadd TA; Buch H; Barton D; Neary R; Clayton RN
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):387-93. PubMed ID: 15355457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
    Evans LM; Davies JS; Goodfellow J; Rees JA; Scanlon MF
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):457-64. PubMed ID: 10468904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary flow reserve is impaired in patients with adult growth hormone (GH) deficiency.
    Oflaz H; Sen F; Elitok A; Cimen AO; Onur I; Kasikcioglu E; Korkmaz S; Demirturk M; Kutluturk F; Pamukcu B; Ozbey N
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):524-9. PubMed ID: 17371470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
    Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement.
    Hána V; Prázný M; Marek J; Skrha J; Justová V
    Eur J Endocrinol; 2002 Sep; 147(3):333-7. PubMed ID: 12213670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of E-selectin concentrations may correlate with potential endothelial dysfunction in individuals with hypopituitarism during therapy with growth hormone.
    Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
    Curr Neurovasc Res; 2007 Feb; 4(1):55-62. PubMed ID: 17311545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal vascular reactivity in growth hormone deficiency.
    Capaldo B; Guardasole V; Pardo F; Matarazzo M; Di Rella F; Numis F; Merola B; Longobardi S; Saccà L
    Circulation; 2001 Jan; 103(4):520-4. PubMed ID: 11157716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
    Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
    Pfeifer M; Kanc K; Verhovec R; Kocijancic A
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults.
    Beshyah SA; Shahi M; Skinner E; Sharp P; Foale R; Johnston DG
    Eur J Endocrinol; 1994 May; 130(5):451-8. PubMed ID: 8180671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.
    Götherström G; Bengtsson BA; Sunnerhagen KS; Johannsson G; Svensson J
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):105-13. PubMed ID: 15638878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.